Using the UALCAN database for the protein expression analysis of the CPTAC dataset, the total GNL3L protein acquired from the CPTAC dataset showed raised protein expression levels of GNL3L in tissues of breast cancer, clear cell RCC, colon cancer, lung adenocarcinoma, ovarian cancer, and UCEC compared to normal tissues (Figure 1C). This evidence concerns the gene GNL3L and breast carcinoma.